Global Drug Delivery Devices Market Growth (Status and Outlook) 2025-2031

Global Drug Delivery Devices Market Growth (Status and Outlook) 2025-2031

The global Drug Delivery Devices market size is predicted to grow from US$ 44520 million in 2025 to US$ 59950 million in 2031; it is expected to grow at a CAGR of 5.1% from 2025 to 2031.

Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug delivery devices corresponding to the medicine taken ways, such as syringe, spray bottle and implantable drug delivery devices etc.

The top five global manufacturers of drug delivery equipment are Cipla, Baxter International, Nipro Corporation, Roche and Boehringer Ingelheim, with a combined market share of 29 per cent. North America, which has a well-established healthcare infrastructure and a large number of leading pharmaceutical and biopharmaceutical companies (around 80% of the worlds research and development in biopharmaceutical is conducted by US-based firms), is the largest market for drug delivery, about for 47% followed by Europe with 28%.

LPI (LP Information)' newest research report, the “Drug Delivery Devices Industry Forecast” looks at past sales and reviews total world Drug Delivery Devices sales in 2024, providing a comprehensive analysis by region and market sector of projected Drug Delivery Devices sales for 2025 through 2031. With Drug Delivery Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Delivery Devices industry.

This Insight Report provides a comprehensive analysis of the global Drug Delivery Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Drug Delivery Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drug Delivery Devices market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Delivery Devices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Delivery Devices.

This report presents a comprehensive overview, market shares, and growth opportunities of Drug Delivery Devices market by product type, application, key players and key regions and countries.

Segmentation by Type:
Injection Type
Mucosal Type
Implanted Type
Others Type

Segmentation by Application:
Pharmaceutical Companies
Hospitals
Clinics
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Cipla
Baxter International
Nipro Corporation
Roche
Boehringer Ingelheim
Allergan
3M
BD
Catalent
Valeant Pharmaceuticals
Bayer AG
Chiesi
Phillips-Medisize
Johnson & Johnson
Shandong Weigao
Pfizer
B.Braun
Novartis AG
Zhengkang
Gerresheimer
COVIDIEN Medtronic
Schott forma vitrum
Alkermes
Skyepharma

Please note: The report will take approximately 2 business days to prepare and deliver.